These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 12792781)

  • 21. Expression of CD30 (Ber-H2) in nasopharyngeal carcinoma, undifferentiated type and lymphoepithelioma-like carcinoma. A comparison study with anaplastic large cell lymphoma.
    Kneile JR; Tan G; Suster S; Wakely PE
    Histopathology; 2006 Jun; 48(7):855-61. PubMed ID: 16722935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hodgkin lymphoma. Classification and pathogenesis].
    Foss HD; Marafioti T; Stein H
    Pathologe; 2000 Mar; 21(2):113-23. PubMed ID: 10840817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A histogenetic model for Hodgkin's lymphoma development. A Proposal based on immunophenotypic markers.
    Carbone A
    Adv Clin Path; 2000 Oct; 4(4):192-4. PubMed ID: 11436157
    [No Abstract]   [Full Text] [Related]  

  • 24. [Mental disorders in Hodgkin's Lymphoma].
    Olexenko LV; Vybornykh DE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(8):124-131. PubMed ID: 28884729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CNS lymphoma masquerading as stroke: Cases report and literature review.
    Liang X; Wang C; Liu Y
    J Cell Mol Med; 2023 Dec; 27(23):3939-3947. PubMed ID: 37997520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic susceptibility to Hodgkin's lymphoma and to secondary cancer: workshop report.
    Staratschek-Jox A; Shugart YY; Strom SS; Nagler A; Taylor GM
    Ann Oncol; 2002; 13 Suppl 1():30-3. PubMed ID: 12078899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcuma Contra Cancer? Curcumin and Hodgkin's Lymphoma.
    Kewitz S; Volkmer I; Staege MS
    Cancer Growth Metastasis; 2013; 6():35-52. PubMed ID: 24665206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy's effects on autophagy in the treatment of Hodgkin's lymphoma: a scoping review.
    Wahyudianingsih R; Sanjaya A; Jonathan T; Pranggono EH; Achmad D; Hernowo BS
    Discov Oncol; 2024 Jul; 15(1):269. PubMed ID: 38976168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of Hodgkin's lymphoma-like undifferentiated carcinoma of the nasopharyngeal type as a particular UCNT subtype mimicking Hodgkin's lymphoma.
    Charafe-Jauffret E; Bertucci F; Ramuz O; Devilard E; Gaulard P; Brousset P; Houlgatte R; Hassoun J; Birnbaum D; Xerri L
    Int J Oncol; 2003 Jul; 23(1):97-103. PubMed ID: 12792781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histopathology of Hodgkin's lymphoma.
    Eberle FC; Mani H; Jaffe ES
    Cancer J; 2009; 15(2):129-37. PubMed ID: 19390308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting cellular FLICE-like inhibitory protein as a novel approach to the treatment of Hodgkin's lymphoma.
    Dutton A; Burns AT; Young LS; Murray PG
    Expert Rev Anticancer Ther; 2006 Jun; 6(6):911-9. PubMed ID: 16761935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.
    Keegan TH; Glaser SL; Clarke CA; Gulley ML; Craig FE; Digiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
    J Clin Oncol; 2005 Oct; 23(30):7604-13. PubMed ID: 16186595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Secondary head and neck osteosarcoma following treatment of undifferentiated nasopharyngeal neoplasms (UCNT)].
    Boussen H; Gritli S; Touati S; Chebbi A; Krichen H; Benna F; Saadi A; el May A; Ben Ayed F; Ladgham A
    Bull Cancer; 1997 Dec; 84(12):1115-8. PubMed ID: 9587363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolated nasopharyngeal Hodgkin's disease presenting as nasal obstruction.
    Malis DD; Moffat D; McGarry GW
    Int J Clin Pract; 1998; 52(5):343-6. PubMed ID: 9796568
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.